Globus Medical, Inc. (GMED)

Globus Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,770	2,519	1,568	1,023	958.1	789.04
Revenue Growth (YoY)	11.75%	60.62%	53.34%	6.76%	21.43%	0.47%
Cost of Revenue	899.84	819.88	476.52	262.83	239.22	217.46
Gross Profit	1,870	1,699	1,092	760.01	718.88	571.58
Selling, General & Admin	1,083	977.48	643.41	432.12	408.15	354.76
Research & Development	144.12	161.6	124.01	73.02	97.35	84.52
Amortization of Goodwill & Intangibles	118.75	119.37	51.03	17.74	18.53	16.83
Operating Expenses	1,346	1,258	818.45	522.87	524.02	456.11
Operating Income	523.93	441.03	273.51	237.15	194.86	115.47
Interest Expense	-	-4.19	-	-	-	-
Interest & Investment Income	4.64	-	20.13	14.23	9.3	13.95
Currency Exchange Gain (Loss)	-33.34	-43.29	14.26	-1.02	-1.42	-0.28
Other Non Operating Income (Expenses)	3.1	1.57	-1.35	7.24	3.36	1.38
EBT Excluding Unusual Items	498.34	395.12	306.55	257.6	206.09	130.53
Merger & Restructuring Charges	-123.47	-274.72	-139.93	-6.85	-16.98	-4.03
Gain (Loss) on Sale of Investments	0.99	0.64	-0.79	-5.39	-2.78	-0.59
Legal Settlements	-29.71	-0.31	-0.43	-2.34	-5.92	-0.01
Other Unusual Items	114.36	-	-	-	-	-
Pretax Income	460.5	120.72	165.39	243.02	180.41	125.9
Income Tax Expense	36.72	17.74	42.52	52.85	31.22	23.61
Net Income	423.78	102.98	122.87	190.17	149.19	102.29
Net Income to Common	423.78	102.98	122.87	190.17	149.19	102.29
Net Income Growth	363.08%	-16.19%	-35.39%	27.47%	45.86%	-34.10%
Shares Outstanding (Basic)	136	136	113	100	101	99
Shares Outstanding (Diluted)	138	138	115	103	104	101
Shares Change (YoY)	1.31%	20.27%	11.68%	-0.95%	2.63%	-1.01%
EPS (Basic)	3.12	0.76	1.09	1.89	1.48	1.04
EPS (Diluted)	3.08	0.75	1.07	1.85	1.44	1.01
EPS Growth	358.86%	-29.91%	-42.16%	28.47%	42.57%	-33.55%
Free Cash Flow	579.61	405.21	165.23	104.42	219.38	135.14
Free Cash Flow Per Share	4.21	2.94	1.44	1.02	2.12	1.34
Gross Margin	67.51%	67.46%	69.62%	74.30%	75.03%	72.44%
Operating Margin	18.92%	17.51%	17.44%	23.18%	20.34%	14.63%
Profit Margin	15.30%	4.09%	7.83%	18.59%	15.57%	12.96%
Free Cash Flow Margin	20.93%	16.08%	10.53%	10.21%	22.90%	17.13%
EBITDA	799.64	695.05	418.24	305.4	264.73	178.35
EBITDA Margin	28.87%	27.59%	26.66%	29.86%	27.63%	22.60%
D&A For EBITDA	275.71	254.02	144.73	68.25	69.87	62.87
EBIT	523.93	441.03	273.51	237.15	194.86	115.47
EBIT Margin	18.92%	17.51%	17.44%	23.18%	20.34%	14.63%
Effective Tax Rate	7.98%	14.69%	25.71%	21.75%	17.30%	18.76%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q